...
首页> 外文期刊>Analytical and bioanalytical chemistry >Ultrasound-enhanced surfactant-assisted dispersive liquid-liquid microextraction and high-performance liquid chromatography for determination of ketoconazole and econazole nitrate in human blood
【24h】

Ultrasound-enhanced surfactant-assisted dispersive liquid-liquid microextraction and high-performance liquid chromatography for determination of ketoconazole and econazole nitrate in human blood

机译:超声增强表面活性剂辅助分散液-液微萃取和高效液相色谱法测定人血中的酮康唑和硝酸益康唑

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A simple and efficient method, based on ultrasound-enhanced surfactant-assisted dispersive liquid-liquid microextraction (UESA-DLLME) followed by high-performance liquid chromatography (HPLC) has been developed for extraction and determination of ketoconazole and econazole nitrate in human blood samples. In this method, a common cationic surfactant, cetyltrimethylammonium bromide (CTAB), was used as dispersant. Chloroform (40 μL) as extraction solvent was added rapidly to 5 mL blood containing 0.068 mg mL ~(-1) CTAB. The mixture was then sonicated for 2 min to disperse the organic chloroform phase. After the extraction procedure, the mixture was centrifuged to sediment the organic chloroform phase, which was collected for HPLC analysis. Several conditions, including type and volume of extraction solvent, type and concentration of the surfactant, ultrasound time, extraction temperature, pH, and ionic strength were studied and optimized. Under the optimum conditions, linear calibration curves were obtained in the ranges 4-5000 μg L ~(-1) for ketoconazole and 8-5000 μg L ~(-1) for econazole nitrate, with linear correlation coefficients for both >0.99. The limits of detection (LODs, S/N=3) and enrichment factors (EFs) were 1.1 and 2.3 μg L ~(-1), and 129 and 140 for ketoconazole and econazole nitrate, respectively. Reproducibility and recovery were good. The method was successfully applied to the determination of ketoconazole and econazole nitrate in human blood samples.
机译:建立了一种基于超声增强的表面活性剂辅助分散液-液微萃取(UESA-DLLME)和高效液相色谱(HPLC)的简单有效方法,用于提取和测定人血样品中的酮康唑和硝酸益康唑。在这种方法中,常用的阳离子表面活性剂十六烷基三甲基溴化铵(CTAB)用作分散剂。将氯仿(40μL)作为提取溶剂快速添加到含有0.068 mg mL〜(-1)CTAB的5 mL血液中。然后将混合物超声处理2分钟,以分散有机氯仿相。提取步骤后,将混合物离心以沉淀出有机氯仿相,将其收集用于HPLC分析。研究和优化了几种条件,包括萃取溶剂的类型和体积,表面活性剂的类型和浓度,超声时间,萃取温度,pH和离子强度。在最佳条件下,酮康唑的线性校准曲线在4-5000μgL〜(-1)范围内,硝酸益康唑的线性校准曲线在8-5000μgL〜(-1)范围内,线性相关系数均> 0.99。检出限(LODs,S / N = 3)和富集因子(EFs)分别为1.1和2.3μgL〜(-1),以及酮康唑和硝酸益康唑的129和140。重现性和回收率均良好。该方法已成功用于人体血液样品中酮康唑和硝酸益康唑的测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号